Product Information

ACAMPROSATE CALC DR 333 MG TAB is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.5859 per EA under NDC 68462043518. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Jul 16, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ACAMPROSATE CALC DR 333 MG TAB

Acamprosate Calcium
$0.5859per EA

Strength

333 mg/1

NDC

68462043518

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

ACAMPROSATE CALCIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA202229

FDA Approved

7/16/2013

TE Code

AB

On Market Since

7/16/2013

Price Statistics

The NADAC for ACAMPROSATE CALC DR 333 MG TAB has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 18.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5859 per EA
All-time high$1.1432 (Aug 10, 2016)
All-time low$0.2971 (Nov 20, 2024)
52-week high$0.6218
52-week low$0.5859
Median price$0.6937
Average price$0.6824
Largest weekly change+76.4% (Feb 12, 2025)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-0.5%

3M

-3.7%

6M

-1.6%

1Y

-2.2%

3Y

+16.3%

5Y

-25.0%

All

-18.0%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ACAMPROSATE CALC DR 333 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for ACAMPROSATE CALC DR 333 MG TAB, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.5859 per EA (NDC 68462043518), effective Nov 11, 2026.

How has the price of ACAMPROSATE CALC DR 333 MG TAB changed over time?

Over the history we have for it, the NADAC for ACAMPROSATE CALC DR 333 MG TAB has declined 18.0%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ACAMPROSATE CALC DR 333 MG TAB?

Since Nov 28, 2013, the NADAC for ACAMPROSATE CALC DR 333 MG TAB has ranged from a low of $0.2971 (Nov 20, 2024) to a high of $1.1432 (Aug 10, 2016), with a median of $0.6937 per EA.

Are there cheaper alternatives to ACAMPROSATE CALC DR 333 MG TAB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ACAMPROSATE CALC DR 333 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures ACAMPROSATE CALC DR 333 MG TAB?

ACAMPROSATE CALC DR 333 MG TAB (NDC 68462043518) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.